Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bezafibrate1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
2Bezafibrate (INN 3968)1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 324 💬
3Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8 Days - 7 Years----10件: 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
4Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8-18 Years----10件: 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
5Diagnostic Test: Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days)----10件: 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
6Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 - 18 years)----10件: 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
7Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 Days- 7 years)----10件: 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
8Diagnostic Test: Obtaining Dry Blood Spots From High-risk Newborns (Aged 1-7 Days)----10件: 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
9Elamipretide1件: Elamipretide2件: Elamipretide ,
Elamipretide hydrochloride 💬
--3件: 18, 21, 324 💬
10Triheptanoin1件: Triheptanoin1件: Triheptanoin 💬 --12件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 318, 324, 344 💬